| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1015383950 |
| P356 | DOI | 10.1245/S10434-013-3320-Z |
| P698 | PubMed publication ID | 24121884 |
| P2093 | author name string | Nan Li | |
| Meng-Chao Wu | |||
| Jie Shi | |||
| Shu-Qun Cheng | |||
| Wei-Xing Guo | |||
| Liang-He Yu | |||
| P2860 | cites work | Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 |
| Reactivation of viral replication after liver resection in patients infected with hepatitis B virus | Q28345635 | ||
| Hepatocellular carcinoma | Q29615841 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| Chronic hepatitis B: update 2009 | Q29617409 | ||
| Postoperative adjuvant antiviral therapy for hepatitis B/C virus-related hepatocellular carcinoma: a meta-analysis | Q33920626 | ||
| The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. | Q34004939 | ||
| Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases | Q34390771 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance | Q34546781 | ||
| Lamivudine for patients with chronic hepatitis B and advanced liver disease | Q34551713 | ||
| Occult hepatitis B virus infection and its clinical implications | Q34703532 | ||
| Current status of hepatic resection for hepatocellular carcinoma | Q35953443 | ||
| A study into the risk of exacerbation of chronic hepatitis B after liver resection for hepatocellular carcinoma | Q36806442 | ||
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update | Q37278241 | ||
| A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update | Q37290723 | ||
| EASL Clinical Practice Guidelines: management of chronic hepatitis B. | Q37340737 | ||
| Prevention of hepatocellular carcinoma in hepatitis B virus infection. | Q37585537 | ||
| Immunosuppression following surgical and traumatic injury | Q37782568 | ||
| Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. | Q38503476 | ||
| Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study | Q41968114 | ||
| Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study | Q42272323 | ||
| HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy | Q42907651 | ||
| A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection | Q43281548 | ||
| Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years | Q43914060 | ||
| Hepatitis B e antigen and the risk of hepatocellular carcinoma | Q44068676 | ||
| Histological outcome during long-term lamivudine therapy. | Q44269261 | ||
| Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma | Q44723919 | ||
| Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy. | Q44827502 | ||
| Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. | Q45056487 | ||
| Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study. | Q45268137 | ||
| Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management | Q45268408 | ||
| Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection | Q45353860 | ||
| High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study | Q45357441 | ||
| Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma | Q45360818 | ||
| Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma | Q45363831 | ||
| Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma | Q45365588 | ||
| Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma | Q45399839 | ||
| Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus | Q45407212 | ||
| Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. | Q45511057 | ||
| The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background | Q45521751 | ||
| Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients | Q45730189 | ||
| Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors | Q45739971 | ||
| Predicting cirrhosis risk based on the level of circulating hepatitis B viral load | Q46985831 | ||
| Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B | Q58235862 | ||
| Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case-control study | Q58235887 | ||
| P433 | issue | 3 | |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| hepatectomy | Q1514021 | ||
| P304 | page(s) | 1010-1015 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy? | |
| P478 | volume | 21 |
| Q35270193 | Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma |
| Q50197141 | Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy |
| Q41404394 | Efficacy of combined adjuvant transarterial chemoembolization and antiviral therapy in patients with HBV-related hepatocellular carcinoma after surgery |
| Q37001714 | Feasibility of combining adjuvant transarterial chemoembolization with nucleos(t)ide analog therapy for patients with HBV-associated hepatocellular carcinoma after hepatectomy. |
| Q37164927 | HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study |
| Q33630432 | Hepatitis B virus infection and active replication promote the formation of vascular invasion in hepatocellular carcinoma |
| Q36121202 | Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization |
| Q44309754 | Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma. |
Search more.